PDL BioPharma

PDLI-Q

Higher valuation stocks are going to have a tougher time when people are concerned about a slowing economy. This one has been weakening since March. There is no sign of any real bounce on the little bit of recent strength.

Company is developing compounds which won't harm the body but will help. Multi-billion dollar business. He has owned it for about 3 months and continues to buy.